From practice guidelines to clinical decision support: closing the loop. by Fox, J, Patkar, V, Chronakis, I, Begent, R

TUMOR BINDING-PROPERTIES OF B72.3 FV FRAGMENTS by Owens, R, King, D, Howat, D, Lisle, H, Mountain, A, Harvey, A, Bergin, S, Turner, A, Pedley, B, Boden, J, Begent, R, Yarranton, G

TUMOR-LOCALIZATION OF ENGINEERED ANTIBODY FRAGMENTS by King, D, Mountain, A, Adair, J, Owens, R, Harvey, A, Weir, N, Proudfoot, K, Phipps, A, Lawson, A, Rhind, S, Pedley, B, Boden, J, Boden, R, Begent, R, Yarranton, G

A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomas. by Meyer, T, Gaya, A, Dancey, G, Stratford, MR, Othman, S, Sharma, S, Wellsted, D, Taylor, N, Stirling, J, Poupard, L, Folkes, L, Chan, P, Pedley, R, Chester, K, Owen, K, Violet, J, Malaroda, A, Green, A, Buscombe, J, Padhani, A, Rustin, G, Begent, R